UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000005626
Receipt No. R000006648
Public title Clinical study using positron emission tomography(PET)
Date of disclosure of the study information 2011/05/22
Last modified on 2019/03/12 (Ver. 12)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Clinical study using positron emission tomography(PET)
Acronym PET imaging of Aquapolin-1,4 using TGN020
Scientific Title Clinical study using positron emission tomography(PET)
Scientific Title:Acronym PET imaging of Aquapolin-1,4 using TGN020
Region
Japan

Condition
Condition brain tumor,epilepsy,multiple sclerosis, neuromyelitis,Duchenne musclar dystrophy,Alzheimer's disease,Down Syndrome,Hydrocephalus
Classification by specialty
Neurology Pediatrics Ophthalmology
Neurosurgery Adult Child
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 direct in vivo PET imaging of AQP1,4 distribution
Basic objectives2 Others
Basic objectives -Others A search of the location of abnormality associated with the distribution of AQP1,4
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes in vivo imaging of the distribution of AQP1,4 and clinical condition elucidation of the disease group associated with AQP1,4
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Medicine Device,equipment
Interventions/Control_1 Image analysis for the distribution of AQP1,4 between normalvolunteer and associated patients (once administration)
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria healthy adult volunteer and patients of disease associated with AQP4
Key exclusion criteria The person that an examination for 30-minute imaging is impossible
Target sample size 100

Research contact person
Last name of lead principal investigator
1st name Tsutomu
Middle name
Last name Nakada
Organization University of Niigata
Division name Center for Integrated Human Brain Science
Zip code 951-8585
Address Asahimatchi 1-757,Chuo-ku,Niigata
TEL 025-227-0683
Email tnakada@bri.niigata-u.ac.jp

Public contact
1st name of contact person
1st name Yuji
Middle name
Last name Suzuki
Organization University of Niigata
Division name Center for Integrated Human Brain Science
Zip code 951-8585
Address Asahimatchi 1-757,Chuo-ku,Niigata
TEL 025-227-0683
Homepage URL
Email yuji-s@bri.niigata-u.ac.jp

Sponsor
Institute Center for Integrated Human Brain Science, Brain Research Institute, University of Niigata
Institute
Department

Funding Source
Organization Ministry of Education, Culture, Sport, Science and Technology
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization University of Niigata
Address Asahimatchi 1-757,Chuo-ku,Niigata
Tel 025-227-2006
Email shomu@med.niigata-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2011 Year 05 Month 22 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2011 Year 06 Month 01 Day
Date of IRB
2011 Year 04 Month 14 Day
Anticipated trial start date
2011 Year 06 Month 01 Day
Last follow-up date
2019 Year 02 Month 28 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2011 Year 05 Month 22 Day
Last modified on
2019 Year 03 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006648